Generate Biomedicines, Inc. (GENB) Sharpe Ratio

Sharpe ratio is not yet available for GENB. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.

How it compares to other similar stocks

The table compares Generate Biomedicines, Inc.'s Sharpe Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how GENB's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 8, 2026.

Symbol	Name	1Y Sharpe Ratio
RVMDW	Revolution Medicines Inc. Warrant	12.40
SLGL	Sol-Gel Technologies Ltd.	9.82
CLYM	Climb Bio Inc	7.60
ERAS	Erasca, Inc.	6.43
NBTX	Nanobiotix S.A.	6.19
OVID	Ovid Therapeutics Inc.	5.93
DRTSW	Alpha Tau Medical Ltd. Warrant	5.77
TNGX	Tango Therapeutics, Inc.	5.49
ARWR	Arrowhead Pharmaceuticals, Inc.	5.32
ANRO	Alto Neuroscience, Inc	5.27
GENB	Generate Biomedicines, Inc.	—

Benchmark Against

Benchmark

S&P 500 Index

Lookback Period

How to choose period

Historical Sharpe Ratio

The chart shows GENB's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when GENB consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sharpe Ratio Calculator

How does GENB fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio